Detalles de la búsqueda
1.
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry.
Lancet Oncol
; 24(4): 335-346, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36898391
2.
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation.
Cancer Immunol Immunother
; 71(4): 865-874, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-34462870
3.
A randomized phase III study of fractionated docetaxel, oxaliplatin, capecitabine (low-tox) vs epirubicin, oxaliplatin and capecitabine (eox) in patients with locally advanced unresectable or metastatic gastric cancer: the lega trial.
Gastric Cancer
; 25(4): 783-793, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35352176
4.
A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement?
Support Care Cancer
; 30(3): 2455-2465, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34779921
5.
PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort.
J Transl Med
; 19(1): 270, 2021 06 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34167578
6.
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50.
Cancer Immunol Immunother
; 69(11): 2209-2221, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32474768
7.
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study.
Oncologist
; 24(6): e327-e337, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30796151
8.
Role of NRAS mutations as prognostic and predictive markers in metastatic colorectal cancer.
Int J Cancer
; 136(1): 83-90, 2015 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24806288
9.
From conventional chemotherapy to targeted therapy: use of monoclonal antibodies (moAbs) in gastrointestinal (GI) tumors.
Tumour Biol
; 35(9): 8471-82, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25062724
10.
Focus on genetic and epigenetic events of colorectal cancer pathogenesis: implications for molecular diagnosis.
Tumour Biol
; 35(7): 6195-206, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25051912
11.
Efficacy of Regorafenib and Trifluridine/Tipiracil According to Extended RAS Evaluation in Advanced Metastatic Colorectal Cancer Patients: A Multicenter Retrospective Analysis.
Target Oncol
; 19(3): 371-382, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38613732
12.
Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed.
Eur J Cancer
; 202: 114006, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38489861
13.
Breast adenomyoepithelioma: a case report with malignant proliferation of epithelial and myoepithelial elements.
World J Surg Oncol
; 11: 285, 2013 Oct 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-24171817
14.
Treatment Settings and Outcomes with Regorafenib and Trifluridine/Tipiracil at Third-Line Treatment and beyond in Metastatic Colorectal Cancer: A Real-World Multicenter Retrospective Study.
Curr Oncol
; 30(6): 5456-5469, 2023 06 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37366896
15.
Retrospective Correlation between First Drug Treatment Duration and Survival Outcomes in Sequential Treatment with Regorafenib and Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer: A Real-World Subgroup Analysis.
Cancers (Basel)
; 15(24)2023 Dec 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38136304
16.
Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer.
Nat Med
; 29(3): 605-614, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36864254
17.
Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer.
J Clin Oncol
; 41(15): 2800-2814, 2023 05 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36720089
18.
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study.
J Natl Cancer Inst
; 115(7): 796-804, 2023 07 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37042716
19.
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer.
Clin Cancer Res
; 29(14): 2714-2724, 2023 07 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37125965
20.
Bevacizumab plus chemotherapy in metastatic colorectal cancer patients treated in clinical practice.
Future Oncol
; 8(9): 1193-7, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23030493